Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

COVID-19 Response Fund

Date added:

Strengthening local and national healthcare infrastructure including funding of additional medical personnel, sourcing of medicines and medical equipment, Establishing digital platforms for COVID-19 related data collection, remote delivery of heal

Amount
$20M
Agency or Funder
Novartis
Foreign participation? (where known)
Yes

Special Call on Coronaviruses

Date added:

Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.

Amount
CHF 5M
Agency or Funder
Swiss Nation Science Foundation
Foreign participation? (where known)
Yes
Date application deadline

A Swiss funding call for research on COVID-19 diagnostics, immunology and interventions

Date added:

Support for researchers from four partner universities in Switzerland on diagnostics, human immune response, medical interventions and disease management.

Amount
0.5M to 2.5M CHF
Agency or Funder
Botnar Research Centre for Child Health (BRCCH) at University of Basel & ETH Zurich
Eligibility (if available)

Researchers from its four partner institutions (University of Basel, ETH Zurich, University Children’s Hospital Basel and Swiss Tropical and Public Health Institute)/ Multi-institutional consortia and collaborations with national or international researchers are encouraged.

Foreign participation? (where known)
Yes
Date application deadline

Insights into COVID-19 and the Global Compact for Migration

Date added:

Researcher required to provide insight into how the Global Compact for Migration was used in the COVID-19 crisis, what lessons can be learnt from it, and what implications the pandemic may have for the future of the agreement.

Amount
Unspecified
Agency or Funder
Mixed Migration Centre
Eligibility (if available)

Consultants with 3 to 4 years of experience

Date application deadline

Swiss national COVID-19 research programme

Date added:

Projects must advance the understanding of COVID-19 and the development of vaccines, therapeutics, and diagnostics. Multidisciplinary collaborations and use of international research networks are encouraged.

Amount
CHF 20M
Agency or Funder
Swiss National Science Foundation
Eligibility (if available)

Independent researchers holding a PhD or equivalent

Foreign participation? (where known)
Yes
Date application deadline

The impact of COVID-19 on rheumatic musculoskeletal diseases

Date added:

Funding for projects exploring the clinical course of COVID-19, diagnostic and therapeutic challenges and pathogenic mechanisms in patients with rheumatic musculoskeletal diseases.

Amount
Up to €300,000
Agency or Funder
FOREUM Foundation for Research in Rheumatology
Eligibility (if available)

Oganisations from countries that are members of the European League Against Rheumatism. Organisations from elsewhere can participate as partners but are not eligible to receive funding

Foreign participation? (where known)
Yes
Date application deadline

COVID-19 research in any scientific field by researchers from Switzerland and Asia

Date added:

Funding for collaborative projects between researchers from Switzerland and China, Japan, South Korea or the ASEAN Region in any discipline.

Amount
Up to 25,000 CHF
Agency or Funder
ETH Zürich
Eligibility (if available)

Researchers from Switzerland and Asian countries

Foreign participation? (where known)
Yes
Date application deadline

COVID-19's impact on reproduction, pregnancy, and foetal and neonatal health

Date added:

Exploratory, basic, and clinical research should address but is not limited to COVID-19 in patients at different pregnancy stages, and its impact on ongoing fertility care, gametes and embryos from patients exposed to SARS-CoV-2.

Amount
Up to €25,000
Agency or Funder
Ferring Pharmaceuticals
Foreign participation? (where known)
Yes
Date application deadline